Chakravarty et al., 2008 - Google Patents
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapyChakravarty et al., 2008
View PDF- Document ID
- 18150572953204993509
- Author
- Chakravarty R
- Pandey U
- Manolkar R
- Dash A
- Venkatesh M
- Pillai M
- Publication year
- Publication venue
- Nuclear medicine and biology
External Links
Snippet
90Y of high specific activity and very high radionuclidic purity (> 99.998%) is essential for targeted therapy. Since the current methods used for the preparation of 90Y from 90Sr are not adaptable for use in a central/hospital radiopharmacy, a simple 90Sr–90Y generator …
- 238000000926 separation method 0 title abstract description 42
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
- G21G2001/0042—Technetium
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chakravarty et al. | Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy | |
| Radchenko et al. | Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes | |
| Domnanich et al. | Production and separation of 43 Sc for radiopharmaceutical purposes | |
| Lebedev et al. | Radiochemical separation of no-carrier-added 177Lu as produced via the 176Ybn, γ177Yb→ 177Lu process | |
| Nelson et al. | Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers | |
| Martini et al. | A solvent-extraction module for cyclotron production of high-purity technetium-99m | |
| Tieu et al. | Rapid and automated production of [68Ga] gallium chloride and [68Ga] Ga-DOTA-TATE on a medical cyclotron | |
| US20190307909A1 (en) | Production of 43sc radionuclide and its use in positron emission tomography | |
| Chakravarty et al. | An electro-amalgamation approach to isolate no-carrier-added 177Lu from neutron irradiated Yb for biomedical applications | |
| Perron et al. | Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories | |
| Nelson et al. | High yield cyclotron production of a novel 133/135La theranostic pair for nuclear medicine | |
| Ivanov et al. | Evaluation of the separation and purification of 227Th from its decay progeny by anion exchange and extraction chromatography | |
| Chattopadhyay et al. | Recovery of 99mTc from Na2 [99Mo] MoO4 solution obtained from reactor-produced (n, γ) 99Mo using a tiny Dowex-1 column in tandem with a small alumina column | |
| Abel et al. | Production, collection, and purification of 47Ca for the generation of 47Sc through isotope harvesting at the national superconducting cyclotron laboratory | |
| Braccini et al. | Optimization of 68Ga production at an 18 MeV medical cyclotron with solid targets by means of cross-section measurement of 66Ga, 67Ga and 68Ga | |
| Mastren et al. | A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications | |
| Chakravarty et al. | An electrochemical approach for removal of radionuclidic contaminants of Eu from 153Sm for effective use in metastatic bone pain palliation | |
| Park et al. | Lu-177 preparation for radiotherapy application | |
| Fukumura et al. | An improved 62Zn/62Cu generator based on a cation exchanger and its fully remote-controlled preparation for clinical use | |
| Chakravarty et al. | Reactor production and electrochemical purification of 169Er: a potential step forward for its utilization in in vivo therapeutic applications | |
| Chakravarty et al. | Facile radiochemical separation of clinical-grade 90Y from 90Sr by selective precipitation for targeted radionuclide therapy | |
| Hou et al. | Use of 99mTc from a commercial 99Mo/99mTc generator as yield tracer for the determination of 99Tc at low levels | |
| Rösch, Jörg Brockmann, Nikolai A. Lebedev, Syed M. Qaim | Production and radiochemical separation of the Auger electron emitter 140Nd | |
| Chakravarty et al. | A novel electrochemical 99 Mo/99m Tc generator | |
| Baimukhanova et al. | An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT) |